$444 Million is the total value of WILKINS INVESTMENT COUNSEL INC's 79 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 20.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRK | Buy | Merck | $16,947,000 | +7.5% | 206,544 | +0.5% | 3.82% | +9.8% |
| INTC | Buy | Intel | $14,243,000 | -2.6% | 287,398 | +1.2% | 3.21% | -0.6% |
| IFF | Buy | International Flavors & Fragra | $12,031,000 | -11.6% | 91,612 | +1.4% | 2.71% | -9.8% |
| NVS | Buy | Novartis | $11,748,000 | +1.1% | 133,880 | +0.8% | 2.65% | +3.3% |
| MDT | Buy | Medtronic PLC | $10,925,000 | +9.6% | 98,465 | +2.2% | 2.46% | +11.9% |
| MMM | Buy | 3M | $10,521,000 | -4.0% | 70,665 | +14.5% | 2.37% | -2.0% |
| FTNT | Buy | Fortinet | $8,631,000 | -4.4% | 25,255 | +0.5% | 1.94% | -2.5% |
| IBM | Buy | International Business Machine | $7,169,000 | +32.6% | 55,135 | +36.4% | 1.62% | +35.5% |
| TXN | Buy | Texas Instruments | $6,554,000 | +22.1% | 35,720 | +25.5% | 1.48% | +24.6% |
| IT | Buy | Gartner | $6,134,000 | -9.9% | 20,620 | +1.3% | 1.38% | -7.9% |
| FISV | Buy | Fiserv | $4,940,000 | +25.3% | 48,720 | +28.3% | 1.11% | +27.9% |
| CHRW | Buy | C. H. Robinson Worldwide | $4,683,000 | +0.4% | 43,475 | +0.3% | 1.06% | +2.4% |
| V | Buy | Visa | $2,111,000 | +40.6% | 9,518 | +37.4% | 0.48% | +43.8% |
| AMZN | Buy | Amazon | $1,043,000 | +95.7% | 320 | +100.0% | 0.24% | +99.2% |
| AAPL | Buy | Apple Computer | $468,000 | +40.1% | 2,682 | +42.5% | 0.10% | +41.9% |
| SO | New | Southern | $210,000 | – | 2,900 | +100.0% | 0.05% | – |
| BMY | New | Bristol-Myers Squibb | $204,000 | – | 2,800 | +100.0% | 0.05% | – |
| CNI | New | Canadian National Railway | $201,000 | – | 1,500 | +100.0% | 0.04% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-10
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Merck | 42 | Q3 2023 | 5.7% |
| Newmont Mining | 42 | Q3 2023 | 7.2% |
| Procter & Gamble | 42 | Q3 2023 | 4.9% |
| Intel | 42 | Q3 2023 | 5.0% |
| Johnson & Johnson | 42 | Q3 2023 | 3.7% |
| International Flavors & Fragra | 42 | Q3 2023 | 4.2% |
| Automatic Data Processing | 42 | Q3 2023 | 3.9% |
| Sysco | 42 | Q3 2023 | 4.2% |
| Northern Trust | 42 | Q3 2023 | 4.0% |
| Novartis AG (ADR) | 42 | Q3 2023 | 3.7% |
View WILKINS INVESTMENT COUNSEL INC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-12 |
| 13F-HR | 2023-11-09 |
| 13F-HR | 2023-08-07 |
| 13F-HR | 2023-05-08 |
| 13F-HR | 2023-02-07 |
| 13F-HR | 2022-11-08 |
| 13F-HR | 2022-08-08 |
| 13F-HR | 2022-05-10 |
| 13F-HR | 2022-02-10 |
| 13F-HR | 2021-11-09 |
View WILKINS INVESTMENT COUNSEL INC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.